Agilent Technologies Inc. (A) | Rumor.io

Agilent Technologies

Attention (50-day avg)0.01%

Attention rank (50-day avg)#591

Bullish sentiment (50-day avg)81%

Price to earnings ratio34.6

Market capitalization49.4B

Earnings per share5.06

Dividend yield (TTM)0.58%

Revenue (annual)6.9B

Net income (annual)1.3B

Social

What share of all stock conversation is about A?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% -0.05	0.01% new	0.01% 0	0% 0

May 28

Agilent Technologies reported better-than-expected Q2 financial results, with earnings per share of $1.49 excluding non-recurring items, beating the FactSet consensus of $1.41.
The company raised its FY26 adjusted EPS guidance above estimates, citing strong execution, market share gains, and solid life sciences instrument sales.
Agilent Technologies shares surged 13% on the earnings beat and raised guidance, reclaiming the 200-day moving average, and the stock received an upgrade to "Buy" from Bank of America Securities.

Generated by AI

Sentiment

Of the messages about A that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% +22.49	70.79% -12.81
Bearish	—	—	0% -22.49	29.21% +12.81

Bullish· May 27

Agilent Technologies reported strong Q2 results, beating expectations and raising FY26 guidance, with revenue growth of 10% and non-GAAP EPS of $1.49.
The company's broad-based growth across all three segments, including life sciences tools and diagnostics, continues to drive momentum, with customers benefiting from Agilent's customer-focused strategy and the Ignite Operating System.
Agilent's operational execution and margin performance were exceptional, with adjusted operating margins hitting 26.4% and EPS outlook raised again, leading to a 11% pop in shares.

Bearish· May 30

Agilent Technologies ($A) Q2 2024 earnings missed revenue expectations, with sales of $1.57B vs. $1.58B expected.
The company cut its guidance for FY 2024, citing slower market recovery, with revenue expected to be $6.4-6.5B and adjusted EPS $5.15-5.25.
Agilent's Q3 outlook also disappointed, with revenue expected to be $1.53-1.57B vs. consensus of $1.72B and EPS $1.25-1.28 vs. consensus of $1.45.

Generated by AI

Topics

Of the messages about A that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Earnings	—	—	50%	8.17%
Macro	—	—	0%	38.6%
Announcements	—	—	50%	7.44%
Controversies	—	—	0%	3.13%
Analysts	—	—	0%	28.48%
Technical Analysis	—	—	0%	14.18%

Earnings· May 27

Agilent Technologies reported Q2 2026 earnings, beating expectations with revenue of $1.83B, up 10% YoY, and non-GAAP EPS of $1.49, up 14% YoY.
The company raised FY26 revenue guidance to $7.39-7.49B and non-GAAP EPS guidance to $6.00-6.10, with Q3 non-GAAP EPS guidance of $1.48-1.50.
Agilent's Q2 2026 performance was driven by strong execution, margin expansion, and positive operational momentum, with the company's CEO stating it was an excellent quarter with broad-based strength across key end markets.

Analysts· May 24

Barclays lowers Agilent Technologies' price target to $135, Equal Weight rating, while Citigroup cuts it to $130, Neutral.
Wells Fargo raises Agilent Technologies' price target to $160, Overweight, while Stifel lowers it to $135, Hold.
Analyst consensus remains strong, with 82% of 25 analysts recommending Agilent Technologies to buy.

Announcements· Nov 20

Agilent Technologies, Inc. ($A) reported Q4 2023 earnings, beating expectations with EPS of $1.38 and revenue of $1.69B.
The company updated its Q1 2024 guidance to $1.20-$1.23 EPS and revenue of $1.555-1.605B, down from previous estimates.
Agilent also updated its FY 2024 guidance to $5.44-$5.55 EPS and revenue of $6.71-6.81B, down from previous estimates.

Generated by AI

Community

Of the messages about A, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	100%	46.07%	22.96%
Newcomers	—	0%	53.93%	77.04%

Regulars· May 27

Agilent's Q2 2026 earnings report showed a strong operational rebound, with adjusted operating margins hitting 26.4% and adjusted EPS of $1.49, beating the market expectation by $0.08 per share.
The company raised its FY26 revenue guidance to $7.39–7.49B and non-GAAP EPS guidance to $6.00–$6.10, following a 10% reported revenue growth and 6.3% core growth in Q2 2026.
Agilent's Q3 non-GAAP EPS guidance is $1.48–$1.50, and the company's Q3 revenue guidance is $1.830B–$1.850B, in-line with market estimates.

Newcomers· Nov 25

Agilent Technologies reported Q4 2025 revenue of $1.86 billion, exceeding guidance with a 7.2% core growth, and its stock price increased.
Agilent Technologies broke its 2025 highs with a 235% volume increase, driven by strong earnings and growth.
The Financial AI accurately predicted Agilent Technologies' Q4 2025 sales and gross income beat, contributing to a 2.344% post-earnings price increase.

Generated by AI

News

Bullish on Agilent Technologies Inc

A technical look at the stock

17h agoThe Globe and Mail

Agilent launches AI cell identification software module

23h agoInvesting.com

Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers

SANTA CLARA, Calif., September 29, 2026--Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent BioTek Gen5 AI cell identification module, a new image analysis software add-on that incorporates AI-based cell identification and segmentation into BioTek Gen5 imaging analysis.

1d agoYahoo Finance

Agilent Technologies Inc. stock outperforms competitors on strong trading day

1d agoMarketWatch

Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Regeneron (REGN)

Tipranks Press Release.

2d agoThe Globe and Mail

Agilent Technologies (A) Tests Valuation On Exchange Offer And Recurring Revenue Story

Agilent Technologies (A) drew fresh investor attention after announcing a fixed income exchange offer for its 4.900% senior unsecured notes due January 15, 2032, covering a principal amount of US$600 million. Recent action around Agilent Technologies reflects that investors are leaning into the story again, with a 7 day share price return of 10.43% and a 90 day share price return of 30.08% helping lift the stock to US$172.79. That momentum sits on top of a 1 year total shareholder return of...

3d agoYahoo Finance

Also Discussed

Investors talking about A also mention

#	Name	Attention
1	Barrick Mining CorporationB	0%0
2	CVR Partners, LP Common Units Representing Limited Partner InterestsUAN	0%0
3	Genpact LimitedG	0.02%new
4	Citigroup Inc. Common StockC	0%-0.01
5	Dominion Energy, Inc.D	0%0
6	Ryder System Inc.R	0%new
7	Loews CorporationL	0%0
8	Jacobs Solutions Inc.J	0%0
9	Eni S.p.A. Sponsored ADRE	0%0
10	Two Harbors Investment Corp.TWO	0%0

Agilent Technologies Inc.

Healthcare
Diagnostics & Research

Agilent Technologies Inc. is a global life sciences, diagnostics, and applied markets company that provides instruments, software, consumables, and services for laboratory and analytical workflows. Its portfolio supports research, routine testing, and regulated environments across pharmaceuticals, clinical diagnostics, food safety, environmental analysis, and materials science. The company’s offerings include chromatography and mass spectrometry systems, spectroscopy tools, pathology and genomics solutions, laboratory informatics, and a broad range of consumables and support services. Agilent Technologies Inc. serves scientific, industrial, and healthcare customers that rely on precise measurement, sample analysis, and workflow efficiency. Through its lab-focused product and service mix, the company plays a central role in enabling data-driven decisions in research, quality control, and diagnostic testing across global markets.

Website

Location

5301 Stevens Creek Boulevard

Santa Clara, CA, 95051

United States

Social

What share of all stock conversation is about A?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% -0.05	0.01% new	0.01% 0	0% 0

May 28

Agilent Technologies reported better-than-expected Q2 financial results, with earnings per share of $1.49 excluding non-recurring items, beating the FactSet consensus of $1.41.
The company raised its FY26 adjusted EPS guidance above estimates, citing strong execution, market share gains, and solid life sciences instrument sales.
Agilent Technologies shares surged 13% on the earnings beat and raised guidance, reclaiming the 200-day moving average, and the stock received an upgrade to "Buy" from Bank of America Securities.

Generated by AI

Sentiment

Of the messages about A that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	100% +22.49	70.79% -12.81
Bearish	—	—	0% -22.49	29.21% +12.81

Bullish· May 27

Agilent Technologies reported strong Q2 results, beating expectations and raising FY26 guidance, with revenue growth of 10% and non-GAAP EPS of $1.49.
The company's broad-based growth across all three segments, including life sciences tools and diagnostics, continues to drive momentum, with customers benefiting from Agilent's customer-focused strategy and the Ignite Operating System.
Agilent's operational execution and margin performance were exceptional, with adjusted operating margins hitting 26.4% and EPS outlook raised again, leading to a 11% pop in shares.

Bearish· May 30

Agilent Technologies ($A) Q2 2024 earnings missed revenue expectations, with sales of $1.57B vs. $1.58B expected.
The company cut its guidance for FY 2024, citing slower market recovery, with revenue expected to be $6.4-6.5B and adjusted EPS $5.15-5.25.
Agilent's Q3 outlook also disappointed, with revenue expected to be $1.53-1.57B vs. consensus of $1.72B and EPS $1.25-1.28 vs. consensus of $1.45.

Generated by AI

Topics

Of the messages about A that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Earnings	—	—	50%	8.17%
Macro	—	—	0%	38.6%
Announcements	—	—	50%	7.44%
Controversies	—	—	0%	3.13%
Analysts	—	—	0%	28.48%
Technical Analysis	—	—	0%	14.18%

Earnings· May 27

Agilent Technologies reported Q2 2026 earnings, beating expectations with revenue of $1.83B, up 10% YoY, and non-GAAP EPS of $1.49, up 14% YoY.
The company raised FY26 revenue guidance to $7.39-7.49B and non-GAAP EPS guidance to $6.00-6.10, with Q3 non-GAAP EPS guidance of $1.48-1.50.
Agilent's Q2 2026 performance was driven by strong execution, margin expansion, and positive operational momentum, with the company's CEO stating it was an excellent quarter with broad-based strength across key end markets.

Analysts· May 24

Barclays lowers Agilent Technologies' price target to $135, Equal Weight rating, while Citigroup cuts it to $130, Neutral.
Wells Fargo raises Agilent Technologies' price target to $160, Overweight, while Stifel lowers it to $135, Hold.
Analyst consensus remains strong, with 82% of 25 analysts recommending Agilent Technologies to buy.

Announcements· Nov 20

Agilent Technologies, Inc. ($A) reported Q4 2023 earnings, beating expectations with EPS of $1.38 and revenue of $1.69B.
The company updated its Q1 2024 guidance to $1.20-$1.23 EPS and revenue of $1.555-1.605B, down from previous estimates.
Agilent also updated its FY 2024 guidance to $5.44-$5.55 EPS and revenue of $6.71-6.81B, down from previous estimates.

Generated by AI

Community

Of the messages about A, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	100%	46.07%	22.96%
Newcomers	—	0%	53.93%	77.04%

Regulars· May 27

Agilent's Q2 2026 earnings report showed a strong operational rebound, with adjusted operating margins hitting 26.4% and adjusted EPS of $1.49, beating the market expectation by $0.08 per share.
The company raised its FY26 revenue guidance to $7.39–7.49B and non-GAAP EPS guidance to $6.00–$6.10, following a 10% reported revenue growth and 6.3% core growth in Q2 2026.
Agilent's Q3 non-GAAP EPS guidance is $1.48–$1.50, and the company's Q3 revenue guidance is $1.830B–$1.850B, in-line with market estimates.

Newcomers· Nov 25

Agilent Technologies reported Q4 2025 revenue of $1.86 billion, exceeding guidance with a 7.2% core growth, and its stock price increased.
Agilent Technologies broke its 2025 highs with a 235% volume increase, driven by strong earnings and growth.
The Financial AI accurately predicted Agilent Technologies' Q4 2025 sales and gross income beat, contributing to a 2.344% post-earnings price increase.

Generated by AI

Agilent Technologies

Social

May 28

Bullish· May 27

Bearish· May 30

Earnings· May 27

Analysts· May 24

Announcements· Nov 20

Regulars· May 27

Newcomers· Nov 25

Bullish on Agilent Technologies Inc

Agilent launches AI cell identification software module

Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers

Agilent Technologies Inc. stock outperforms competitors on strong trading day

Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Regeneron (REGN)

Agilent Technologies (A) Tests Valuation On Exchange Offer And Recurring Revenue Story

Also Discussed

Agilent Technologies Inc.

Company Information

Location

Bullish on Agilent Technologies Inc

Agilent launches AI cell identification software module

Agilent Introduces Gen5 AI Cell Identification Module for BioTek Automated Cell Imagers

Agilent Technologies Inc. stock outperforms competitors on strong trading day

Analysts Are Bullish on Top Healthcare Stocks: Agilent (A), Regeneron (REGN)

Agilent Technologies (A) Tests Valuation On Exchange Offer And Recurring Revenue Story

Also Discussed

Social

May 28

Bullish· May 27

Bearish· May 30

Earnings· May 27

Analysts· May 24

Announcements· Nov 20

Regulars· May 27

Newcomers· Nov 25